Matthew C. Abernethy
2021
Compensation breakdown
| Bonus | $264,960 |
|---|---|
| Option Awards | $2,625,019 |
| Salary | $588,800 |
| Stock Awards | $2,375,068 |
| Other | $53,003 |
| Total | $5,906,850 |
Abernethy received $2.6M in option awards, accounting for 44% of the total pay in 2021.
Abernethy also received $265K in bonus, $588.8K in salary, $2.4M in stock awards and $53K in other compensation.
Rankings
In 2021, Matthew C. Abernethy's compensation ranked 2,147th out of 12,415 executives tracked by ExecPay. In other words, Abernethy earned more than 82.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,147 out of 12,415 | 83rd |
Division Manufacturing | 830 out of 5,505 | 85th |
Major group Chemicals And Allied Products | 316 out of 2,375 | 87th |
Industry group Drugs | 274 out of 2,096 | 87th |
Industry Biological Products, Except Diagnostic Substances | 85 out of 449 | 81st |
Pay ratio
| Matthew C. Abernethy's Pay | $5,906,850 |
|---|---|
| Median Employee's Pay | $276,598 |
| Pay Ratio | 21to 1 |
In 2021, the annual total compensation of Matthew C. Abernethy was $5,906,850.
The annual total compensation of the median employee at Neurocrine Biosciences was $276,598.
The ratio of Matthew C. Abernethy's pay to the pay of median employee was therefore 21 to one.
Abernethy's colleagues
We found four more compensation records of executives who worked with Matthew C. Abernethy at Neurocrine Biosciences in 2021.
News
April 7, 2022
April 9, 2021
April 9, 2020
April 17, 2019